Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents [In Process Citation]. Biochem Pharmacol 2000;60:1051-1059.

Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-1886.

Anonymous. “Some prostate problems may benefit from over-the-counter help.” Environmental Nutrition 2000;23:1-6 (not inclusive).

Bibra WG. Lycopene. Toxicity profile BIBRA. Toxicology International 1900.

Blumenfeld AJ, Fleshner N, Casselman B, Trachtenberg J. Nutritional aspects of prostate cancer: a review. Can J Urol 2000 Feb.;7(1):927.-935. 7:927-935.

Braeckman J. The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a multicenter open study. Curr Ther Res 1994;55:776-785.

Brawley OW, Parnes H. Prostate cancer prevention trials in the USA. Eur J Cancer 2000;36:1312-1315.

Bronner WE, Beecher GR. Method for determining the content of catechins in tea infusions by high performance liquid chromatography. J Chromatogr A 1998;805:137-142.

Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate 1996;29:231-240.

Champault G. A Double-Blind Trial of an Extract of the Pant Serenoa repens in Benign Prostatic Hyperplasia. British Journal of Pharmac. 1984;18:

Champault G. The Medical Treatment of Prostatic Adenoma A Controlled Study. Actualite Therapeutique, Ann.Urol. 1984;407-410.

Chan JM, Stampfer MJ, Giovannucci EL. What causes prostate cancer? A brief summary of the epidemiology. Semin.Cancer Biol 1998;8:263-273.

Clark LC, Combs GFJ, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-1963.

Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81:730-734.

Clinton, S. K., Emenhiser, C., Schwartz, S. J., Bostwick, D. G., Williams, A. W., Moore, B. J., and Erdman, J. W. Jr. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev. 5(10), 823-833. 1996.

Cohen LA, Zhao Z, Pittman B, Khachik F. Effect of dietary lycopene on N-methylnitrosourea-induced mammary tumorigenesis. Nutr Cancer 1999;34:153-159.

Combs GFJ, Clark LC, Turnbull BW. Reduction of cancer mortality and incidence by selenium supplementation. Med Klin 1997;92 Suppl 3:42-45.

Criqui MH, Bangdiwala S, Goodman DS, et al. Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Ann Epidemiol 1991;1:385-393.

Di Mascio, P., Murphy, M. E., and Sies, H. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 53(1 Suppl), 194S-200S. 1991

Di Silverio F, D'Eramo G, Lubrano C, et al. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol 1992;21:309-314.

Emili E. Risultati Clinici su un Nuovo Farmaco nella Terapia dell'Ipertrofia Prostata (Permixon). Urologia 1983;1042-1048.

Fair WR, Fleshner NE, Heston W. Cancer of the prostate: a nutritional disease? Urology 1997;50:840-848.

Fleshner NE, Klotz LH. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 1998;17:325-330.

Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Research 1999;59:1225-1230.

Gerster H. The potential role of lycopene for human health. J.Am.Coll.Nutr. 1997;16:109-126.

Ghadirian P, Maisonneuve P, Perret C, et al. A case-control study of toenail selenium and cancer of the breast, colon, and prostate [In Process Citation]. Cancer Detect.Prev 2000;24.(4):305.-13.

Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J.Natl.Cancer Inst. 1999;91:317-331.

Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 1999;59:2115-2120.

Gupta S, Ahmad N, Mukhtar H. Prostate cancer chemoprevention by green tea. Semin.Urol Oncol 1999;17:70-76.

Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 2000;164:82-90.

Gutierrez M. Mechanisms Involved in the Spasmolytic Effect of Extracts from Sabal serrulata Fruit on Smooth Muscle. Gen.Pharmac. 1996;27:171-176.

Gutierrez M. Spasmolytic Activity of a Lipidic Extract from Sabal serrulata Fruits Further Study of the Mechanisms Underlying this Activity. Planta M 1996;507-511.

Hathcock, J. N. Vitamin and Mineral Safety. 1997. Washington, DC, Council for Responsible Nutrition.

Ip C, Birringer M, Block E, et al. Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem 2000;48(6):2062-2070.

Isensee H. Cardioprotective Actions of Garlic (Allium Sativum). Arzneim-Forsch/Drug Research 1993;43(1):94-98.

Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000;141:980-987.

Koch E, Biber A. Pharmacological effects of sabal and urtica extracts as basis for a rational drug therapy in benign prostate hyperplasia. <Original> Pharmakologische wirkungen von sab. Urologe Ausg.B 1994;34:90-95.

Kumar NB, Besterman-Dahan K. Nutrients in the Chemoprevention of Prostate Cancer: Current and Future Prospects. Cancer Control. 1999;6:580-586.

Lee IP, Kim YH, Kang MH, Roberts C, Shim JS, Roh JK. Chemopreventive effect of green tea (Camellia sinensis) against cigarette smoke-induced mutations (SCE) in humans. J.Cell.Biochem. 1997;64:68-75.

Liao S, Hiipakka RA. Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys.Res Commun 1995;214:833-838.

Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 1995;96:239-243.

Lyn-Cook BD, Rogers T, Yan Y, Blann EB, Kadlubar FF, Hammons GJ. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer 1999;35:80-86.

Mayne ST, Cartmel B, Silva F, et al. Plasma lycopene concentrations in humans are determined by lycopene intake, plasma cholesterol concentrations and selected demographic factors. Journal of Nutrition 1999;129:849-854.

Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth [In Process Citation]. Cancer Epidemiol Biomarkers Prev 2000;9:1171-1182.

Nelson MA, Porterfield BW, Jacobs ET, Clark LC. Selenium and prostate cancer prevention. Semin.Urol Oncol 1999;17:91-96.

Nomura AM, Lee J, Stemmermann GN, Combs GFJ. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2000;9:883-887.

Paschka AG, Butler R, Young CY. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Letters 1998;130:1-7.

Pastori, M., Pfander, H., Boscoboinik, D., and Azzi, A. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys.Res Commun. 250(3), 582-585. 9-29-1998.

Pizzorno J, Murray M. A Textbook of Natural Medicine. John Bastyr College Publications, 1985.

Rao AV, Fleshner N, Agarwal S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case-control study. Nutr.Cancer 1999;33:159-164.

Rhodes L. Comparison of Finasteride (Proscar), a 5a Reductase Inhibitor, and Various Commercial Plant Extracts in In Vitro and In Vivo 5a Reductase Inhibition. Prostate 1993;43-51.

Saw Palmetto (Serenoa repens). In: Duke JA, ed. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, Inc., 1985:75-77.

Saw Palmetto berry. In: Blumenthal M, Goldberg A, Brinckmann J, eds. Herbal Medicine--Expanded Commission E Monographs. Newton,MA: Integrative Medicine Communications, 2000:335-340.

Saw Palmetto. The Lawrence Review of Natural Products 1994;1-2.

Schrauzer GN. Selenomethionine: a review of its nutritional significance, metabolism, and toxicity. J Nutr 2000;130(7):1653-1656.

Shi J, Le Maguer M. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit.Rev Food Sci Nutr 2000 Jan.;40(1):1-42 40:1-42.

Shim, Kang, Kim. Chemopreventive efect of green tea (Camellia sinensis) among Cigarette Smokers. Cancer Epidemiology 1995;4:387-391.

Stenger A. Pharmacological and Biochemical Study of Hexanoic Extract of Serenoa Repens B. Gazette Medicale de France 1982;89:2041-2048.

Sultan C, Terraza A, Devillier C, et al. Inhibition of androgen metabolism and binding by a lipo sterolic extract of serenoa-repens b in human fore skin fibroblasts. 6th International Symposium Of The Journal Of Steroid Chemistry 1984;PARIS, FRANCE, MAY 30-JUNE 1, 1983:515-520.

Tarayre JP, Delhon A, Lauressergues H, et al. Anti-edematous action of a hexane extract from Serenoa repens Bartr. drupes. Ann Phamaceutiques francoises 1983;41:559-570.

Tasca A, Barulli M, Cavazzana A, et al. Treatment of Obstructive Symptomatology in Prostatic Adenoma with an Extract of Serenoa repens: Studio clinico in doppio cieco vs. placebo [Treatment of obstructive symptomology in prostatic adenoma with an extract of Serenoa repens: Double-blind clinical study versus placebo]. Minerva Urologica e Nefrologica 1985;37:87-91.

Thompson IM, Coltman CAJ, Crowley J. Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial. Prostate 1997;33:217-221.

Unpublished. Collected papers on clinical use of Xin Nao Jian. 1999.

Unpublished. Document on Long Term Animal Toxicity Test of Xin Nao Jian. 1999.

Unpublished. Zheng X-F. Acute Toxicity Test of Xin Nao Jian Capsule. 1999.

Vinceti M, Rovesti S, Bergomi M, Vivoli G. The epidemiology of selenium and human cancer. Tumori. 2000;86:105-118.

Weisburger JH. Mechanisms of action of antioxidants as exemplified in vegetables, tomatoes and tea. Food Chem Toxicol 1999;37:943-948.

West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991;2:85-94.

Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl.Cancer Inst 1998;90:1219-1224.

Yu G-P, Hsieh CC, Yu S-Z, Li XL, Jin T. Green-tea consumption and risk of stomach cancer: a population- based case-control study in Shanghai, China. Cancer Causes & Control 1996;6:532-538.